FDA De Novo Summary – Eroxon (DEN22078)

FDA De Novo Summary – Eroxon (DEN22078)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: A copy of the De Novo Summary for Futura Medical Development Ltd.’s Eroxon (DEN22078), classified on June 9, 2023.
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details